Tuesday, 9 July 2019

Questions (485)

Bernard Durkan


485. Deputy Bernard J. Durkan asked the Minister for Health his plans to review the process in regard to the governance of the drugs approval and procurement process with particular reference to facilitating more stakeholder engagement from industry and patients; his plans to extend the timeline for the process; and if he will make a statement on the matter. [29796/19]

View answer

Written answers (Question to Health)

The Department recently completed a tender process for a review of the HSE reimbursement and pricing decision-making process. Mazars has been appointed as the consultancy firm to complete this review.

The review will make recommendations, as considered appropriate, in respect of any required improvements to the HSE’s systems, structures, processes, governance arrangements or use of specialist resources in respect of the review.

In making its recommendations, the review will have regard to best practice regarding the procurement of medicines, the conduct of high-value commercial negotiations, governance, organisational structures, skill-mix and oversight.

The agreement signed with Mazars, sets out the relevant stakeholders to be consulted, including patient representatives.

The review is expected to be completed within three months of commencement and consideration will be given, in due course, to publication of a final report.